新闻
Newsletter (in english)
Register for our Newsletter
May 2011: Pemetrexed Disodium, Imatinib Mesilate, Swissmedic audit, Chinese GMP regulations
January 2011: Analgesics by Dolder: Methadone, Buprenorphine, Pethidin
Controlled substances: Codeine, Bromazepam, Oxaliplatin
September 2010: Oxaliplatin Japan DMF, Bendamustine HCl, Cooperation with The Netherlands Cancer Institute, New contact person for all quality-related requests
June 2010: Generic injectables: extensive, strong growth anticipated
Etoposide, Mycophenolate Mofetil, Codeine, new Business Development Manager
April 2010: In the fast lane with oncology active ingredients from Dolder
Pemetrexed, Oxaliplatin, Zolidronic Acids
January 2010: Dolder means oncology:
Bendamustine HCl, Imatinib Mesylate, and Jiangsu Hengrui
September 2009: CPhI 2009: Dolder’s travel survival kit
Codeine Phosphate Hemihydrate, Generic Oxaliplatin, 5-FU
June 2009: Dolder expands API portfolio and territory
Codeine, Amifostine, Duloxetine HCl, Regulatory Affairs Japan
展会
2012年10月9日-11日，CPHI 法兰克福，我们的展位位于??号展厅??展位。期待在这个医
药领域内最盛大的展会中与您见面。 >更多信息 (english)
与我们联系
鲍丹妮 博士
总经理
电话: +86 (0)21 642 618 96
传真: +86 (21) 642 616 84
电子邮箱
Product list (PDF)
Add this page to your favorites: www.dolder.com/pharma
